BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Resverlogix Corporation 

4820 Richard Road SW
Suite 300
Calgary  Alberta  T3E 6L1  Canada
Phone: 403-254-9252 Fax: 403-256-8495


SEARCH JOBS

View Clinical Trials from BioPharm Insight









 Company News
Resverlogix (RVX.TO) CEO Says It's in Talks With Suitors, After $100M in Q1 Deals 4/28/2015 6:32:05 AM
Resverlogix Corporation (RVX.TO), Shenzhen Hepalink Pharma Strike Deal Worth $450 Million+ 4/27/2015 5:59:57 AM
Resverlogix Corporation (RVX.TO) Receives Two Patents For RVX-208 In China 4/7/2015 6:21:48 AM
EXCLUSIVE: Resverlogix Corporation (RVX.TO) CEO Says Experimental Cardiac Drug Holds High Hopes, As Biotech Booms 3/19/2015 12:26:47 PM
Resverlogix Corporation (RVX.TO) Presents At The Prestigious American College of Cardiology 64th Annual Scientific Session & Expo (ACC.15) 3/16/2015 1:56:22 PM
Resverlogix Corporation (RVX.TO) Collaborates With Emerald Logic To Identify Factors Driving Drug Response And Efficacy In Phase 2 Program 3/4/2015 7:40:15 AM
Resverlogix Corporation (RVX.TO) Presents At Biotech Showcase During J.P. Morgan Week 1/15/2015 10:06:46 AM
Resverlogix Corporation (RVX.TO) Names Michael Sweeney, M.D., As Senior Vice President Of Clinical Development 11/4/2014 8:20:05 AM
Resverlogix Corporation (RVX.TO) Announces Annual General Meeting Voting Results 10/9/2014 9:23:51 AM
Resverlogix Corporation (RVX.TO) Corporate Update Conference Call & Webcast Announcement 10/2/2014 7:54:11 AM
12345678910...